Defibrillator Devices Global Market - Forecast to 2023

Publishing Date : April, 2017
Report Code : HCMD 0120
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Defibrillator devices are class of medical devices used for delivering shock in a controlled and automated manner. These devices are mainly used for therapeutic purposes in cardiovascular critical care management, where electrical shock is required to convert patient’s abnormal heart rhythm into normal heart rhythm to revive the victim of sudden cardiac arrest. These defibrillators help in saving the life of a SCA victim, who would have few minutes lifeline and requires resuscitation to avoid situations, which would lead to serious life threatening circumstances or even sometimes to death of a patient.

 

Defibrillator devices market is segmented on the basis of products, applications, end-users and geography. Products are segmented into devices, consumables and servicing, whereas devices are further segmented into Implantable Cardioverter Defibrillators (ICD’s) and external defibrillators. Implantable cardioverter defibrillators are further segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICD’s) and Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s), similarly external defibrillators are classified into Automated External Defibrillators (AED’s), Wearable cardioverter defibrillators and Advanced Life Support Defibrillators (ALS). Consumables are further segmented into electrode pads, battery & chargers, first aid kits and supplies/rescue kits and others including cables & data cables, carry cases or backpacks, training units, training manikins and cabinets  Applications are segmented into ventricular fibrillation, ventricular tachycardia and bradycardia. End-users are further classified into hospitals, ambulatory surgical centers, homecare, public access care, pre-hospitals and others (clinics & cardiac centers & alternative care centers).

 

According to IQ4I analysis, the defibrillator devices global market is expected to grow at a mid to high single digit CAGR to reach $17,710.8 million by 2023. Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end- users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

 

The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD’s and market expansion opportunities in emerging nations are expected to offer potential opportunities.

 

However, various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD’s and increasing number of defibrillator device recalls due to FDA mandates.

The defibrillator devices global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the defibrillator devices market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Asahi Kasei Corporation (Japan), Medtronic PLC (Ireland), Philips Healthcare (Netherland), Biotronik Se & Co. Kg (Germany), Stryker Corporation (U.S.), LivaNova (U.K.) and Nihon Kohden Corporation (Japan).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN AGING POPULATION AND SUBSEQUENT RISE IN INCIDENCE OF CARDIOVASCULAR DISEASES
        • 3.3.1.2     INCREASING USE OF DEFIBRILLATORS IN PUBLIC ACCESS AREAS
        • 3.3.1.3     FAVORABLE REIMBURSEMENT POLICIES
        • 3.3.1.4     EMERGENCE OF NEXT GENERATION INTEGRATED ICD’S
        • 3.3.1.5     INCREASING TREND FOR MRI COMPATIBLE DEFIBRILLATORS
        • 3.3.1.6     MARKET EXPANSION OPPORTUNITIES IN EMERGING NATIONS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     PATIENT SAFETY RISKS DUE TO CHANCES OF INFECTIONS AND OTHER COMPLICATIONS WHILE USING DEFIBRILLATORS
        • 3.3.2.2     LACK OF AWARENESS ON SUDDEN CARDIAC ARRESTS
        • 3.3.2.3     LACK OF CYBERSECURITY IN ICD’S
        • 3.3.2.4     INCREASING NUMBER OF DEFIBRILLATOR DEVICES PRODUCT RECALLS DUE TO FDA MANDATES
    • 3.4     REIMBURSEMENT SCENARIO
      • 3.4.1     REIMBURSEMENT TABLE
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     INDIA
      • 3.5.4     CHINA
      • 3.5.5     JAPAN
    • 3.6     TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS
      • 3.6.1     NEXT GENERATION ICD’S
      • 3.6.2     CUSTOMIZED DEFIBRILLATOR DEVICES & CONSUMABLES
      • 3.6.3     LEADLESS DEFIBRILLATORS
      • 3.6.4     3D PRINTED MULTIFUNCTIONAL INTEGUMENTARY MEMBRANE DEVICES (MIM) FOR ARRYTHMIAS DIAGNOSIS
      • 3.6.5     AMBULANCE DRONE
      • 3.6.6     AMBULANCE ROBOTIC ASSISTED AED’S IN SMART CITIES
      • 3.6.7     DEFIBRILLATOR DEVICES UNDER CLINICAL TRIAL
    • 3.7     MODE OF OPERATION
      • 3.7.1     EXTERNAL MODE OF OPERATION
      • 3.7.2     INTERNAL MODE OF OPERATION
      • 3.7.3     SYNCHRONIZED MODE OF OPERATION
    • 3.8     PATENT ANALYSIS
    • 3.9     SUPPLY CHAIN ANALYSIS
    • 3.10     PORTER’S FIVE FORCE ANALYSIS
      • 3.10.1     THREAT OF NEW ENTRANTS
      • 3.10.2     THREAT OF SUBSTITUTES
      • 3.10.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.10.4     BARGAINING POWER OF SUPPLIERS
      • 3.10.5     BARGAINING POWER OF BUYERS
    • 3.11     IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES
    • 3.12     MARKET SHARE ANALYSIS
      • 3.12.1     DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.12.2     IMPLANTABLE CARDIOVERTER DEFIBRILLATOR GLOBAL MARKET SHARE ANALYSIS
      • 3.12.3     AUTOMATED EXTERNAL DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
      • 3.12.4     ADVANCED LIFE SUPPORT (ALS) DEFIBRILLATORS GLOBAL MARKET SHARE ANALYSIS
  • 4     DEFIBRILLATOR DEVICES GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     DEVICES
      • 4.2.1     IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD’S)
        • 4.2.1.1     TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (T-ICD’S)
          • 4.2.1.1.1     BIVENTRICULAR ICD’S/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)
          • 4.2.1.1.2     DUAL CHAMBER ICD’S
          • 4.2.1.1.3     SINGLE CHAMBER ICD’S
        • 4.2.1.2     SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICD’S)
      • 4.2.2     EXTERNAL DEFIBRILLATORS
        • 4.2.2.1     AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS)
          • 4.2.2.1.1     SEMI-AUTOMATED AEDS
          • 4.2.2.1.2     FULLY AUTOMATED AED’S
        • 4.2.2.2     WEARABLE CARDIOVERTER DEFIBRILLATORS (WCD)/ WEARABLE EXTERNAL DEFIBRILLATORS (WED)
        • 4.2.2.3     ADVANCED LIFE SUPPORT DEFIBRILLATORS (ALS)
    • 4.3     CONSUMABLES
    • 4.4     SERVICING
  • 5     DEFIBRILLATOR DEVICES GLOBAL MARKET, BY APPLICATIONS
    • 5.1     INTRODUCTION
    • 5.2     VENTRICULAR TACHYCARDIA
    • 5.3     VENTRICULAR FIBRILLATION
    • 5.4     BRADYCARDIA
  • 6     DEFIBRILLATOR DEVICES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     HOME HEALTHCARE PROVIDERS
    • 6.4     AMBULATORY SURGICAL CENTERS
    • 6.5     PUBLIC ACCESS CARE
    • 6.6     PRE-HOSPITAL CARE
    • 6.7     OTHERS
  • 7     DEFIBRILLATOR DEVICES GLOBAL MARKET, BY GEOGRAPHY
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     UNITED STATES (U.S.)
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     FRANCE
      • 7.3.2     ITALY
      • 7.3.3     GERMANY
      • 7.3.4     OTHERS
    • 7.4     ASIA-PACIFIC (APAC)
      • 7.4.1     INDIA
      • 7.4.2     CHINA
      • 7.4.3     JAPAN
      • 7.4.4     OTHERS
    • 7.5     REST OF WORLD (ROW)
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST & OTHERS
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
      • 8.1.1     APPROVAL AS A MAJOR GROWTH STRATEGY OF DEFIBRILLATOR DEVICES PLAYERS
    • 8.2     APPROVALS
    • 8.3     NEW PRODUCT LAUNCH
    • 8.4     OTHER DEVELOPMENTS
    • 8.5     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
    • 8.6     MERGERS & ACQUISITIONS
  • 9     COMPANY PROFILES
    • 9.1     ABBOTT LABORATORIES, INC (ST JUDE MEDICAL, INC.)
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BOSTON SCIENTIFIC CORPORATION
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     BIOTRONIK SE & CO.KG
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     LIVANOVA (SORIN GROUP)
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     MEDTRONIC PLC
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     NIHON KOHDEN CORPORATION
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     PHILIPS HEALTHCARE
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     STRYKER CORPORATION
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 3     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 4     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 5     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 6     DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 7     DEVICES DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 8     AVERAGE SELLING PRICE ($) OF DEFIBRILLATOR DEVICES, BY TYPES
      • TABLE 9     IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 10     IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 11     IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 12     TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 13     TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 14     BIVENTRICULAR ICD’S/CRT-D’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 15     BIVENTRICULAR ICD’S/CRT-D’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 16     DUAL CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 17     DUAL CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 18     SINGLE CHAMBER ICD’S DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 19     SINGLE CHAMBER ICD’S DEVICES NO. OF UNITS, BY REGION (2015-2023) ($MN)
      • TABLE 20     SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES GLOBAL MARKET REVENUE BY REGION (2015-2023) ($MN)
      • TABLE 21     SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 22     EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 23     EXTERNAL DEFIBRILLATORS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 24     AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 25     AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 26     AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 27     SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 28     FULLY AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 29     WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 30     WEARABLE CARDIOVERTER DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 31     ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 32     ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES NO. OF UNITS, BY REGION (2015-2023) (NO’S)
      • TABLE 33     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 34     SERVICING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 35     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 36     VENTRICULAR TACHYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 37     VENTRICULAR FIBRILLATION DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 38     BRADYCARDIA DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 39     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 40     HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 41     HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 42     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 43     PUBLIC ACCESS CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 44     PRE HOSPITAL CARE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 45     OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 46     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 47     NORTH AMERICAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 48     NORTH AMERICAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 49     NORTH AMERICAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 50     NORTH AMERICAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 51     NORTH AMERICAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 52     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 53     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 54     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 55     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 56     EUROPEAN BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 57     EUROPEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 58     EUROPEAN TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 59     EUROPEAN EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 60     EUROPEAN AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 61     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 62     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 63     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 64     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 65     ASIA PACIFIC BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 66     ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 67     ASIA PACIFIC TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 68     ASIA PACIFIC EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 69     ASIA PACIFIC AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 70     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 71     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 72     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 73     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 74     REST OF THE WORLD BY DEVICE MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 75     REST OF THE WORLD IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 76     REST OF THE WORLD TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 77     REST OF THE WORLD EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 78     REST OF THE WORLD AUTOMATED EXTERNAL DEFIBRILLATORS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 79     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 80     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 81     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 82     APPROVALS,(2015-2016)
      • TABLE 83     NEW PRODUCT LAUNCHES,(2014-2017)
      • TABLE 84     OTHER DEVELOPMENTS (2015)
      • TABLE 85     AGREEMENTS & PARTNERSHIPS, (2015-2016)
      • TABLE 86     MERGERS AND ACQUISITIONS, (2016)
      • TABLE 87     ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 88     ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 89     ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 90     ASAHI KASEI CORPORATION : TOTAL REVENUE AND R&D EXPENSES (2014-2016*) ($MN)
      • TABLE 91     ASAHI KASEI CORPORATION : TOTAL REVENUE, BY SEGMENTS, (2014-2016*) ($MN)
      • TABLE 92     ASAHI KASEI CORPORATION : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 93     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 94     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 95     BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 96     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 97     LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 98     LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 99     LIVANOVA, PLC: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 100     MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 101     MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 102     MEDTRONIC PLC: TOTAL REVENUE, BY CARDIAC & VASCULAR GROUP SEGMENTS (2014-2016) ($MN)
      • TABLE 103     MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2014-2016) ($MN)
      • TABLE 104     NIHON KOHDEN CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016*) ($MN)
      • TABLE 105     NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016*) ($MN)
      • TABLE 106     NIHON KOHDEN CORPORATION: TOTAL REVENUE, BY REGIONS (2014-2016*) ($MN)
      • TABLE 107     PHILIPS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 108     PHILIPS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 109     PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 110     STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 111     STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 112     STRYKER CORPORATION: TOTAL REVENUE, BY MEDSURG SEGMENTS, (2014-2016) ($MN)
      • TABLE 113     STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023)
      • FIGURE 2     DEFIBRILLATOR DEVICES GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     DEFIBRILLATOR DEVICES GLOBAL MARKET: TOP-DOWN & BOTTOM-UP APPROACH
      • FIGURE 4     DEFIBRILLATOR DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     DEFIBRILLATOR DEVICES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     DEFIBRILLATOR DEVICES GLOBAL MARKET : MARKET DYNAMICS
      • FIGURE 8     DEFIBRILLATOR DEVICES GLOBAL MARKET: PATENT FILING, BY MAJOR PLAYERS (2012-2016)
      • FIGURE 9     DEFRILLATOR DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     DEFIBRILLATOR DEVICES GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
      • FIGURE 11     IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, 2016 (%)
      • FIGURE 12     DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS,BY MAJOR PLAYERS, 2016 (%)
      • FIGURE 13     IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
      • FIGURE 14     AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
      • FIGURE 15     ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
      • FIGURE 16     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016 V’S 2023) ($MN)
      • FIGURE 17     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY DEVICES, (2016 V’S 2023) ($MN)
      • FIGURE 18     IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 19     TRANSVENOUS IMPLANTABLE DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 20     EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 21     AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 22     AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
      • FIGURE 23     ADVANCED LIFE SUPPORT DEFIBRILLATOR DEVICES GLOBAL MARKET SHARE, BY END-USERS, 2016 (%)
      • FIGURE 24     DEFIBRILLATOR DEVICES GLOBAL MARKET SHARES, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 25     DEFIBRILLATOR DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 26     DEFIBRILLATOR DEVICES GLOBAL MARKET SCENARIO, BY REGION, (2015-2023) ($MN) CAGR (%)
      • FIGURE 27     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY PRODUCTS ($MN), & END-USERS (%), (2016 V’S 2023)
      • FIGURE 28     NORTH AMERICAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 29     U.S. DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 30     U.S. DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 31     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 32     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 33     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%),(2016 V’S 2023)
      • FIGURE 34     EUROPEAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 35     FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 36     FRANCE DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 37     ITALY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%),
      • FIGURE 38     ITALY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 39     GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 40     GERMANY DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 41     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 42     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 43     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 44     ASIA PACIFIC DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 45     INDIA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 46     INDIA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 47     CHINA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 48     CHINA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 49     JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 50     JAPAN DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 51     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 52     OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 53     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023) ($MN)
      • FIGURE 54     REST OF THE WORLD DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 55     BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 56     BRAZIL DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 57     REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 58     REST OF LATIN AMERICA DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 59     MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE & SHARE, BY PRODUCTS ($MN) & END-USERS (%), (2016 V’S 2023)
      • FIGURE 60     MIDDLE EAST & OTHERS DEFIBRILLATOR DEVICES MARKET REVENUE, BY APPLICATIONS, (2016 V’S 2023) ($MN)
      • FIGURE 61     KEY GROWTH STRATEGIES, (2014-2016)
      • FIGURE 62     SWOT: ABBOTT LABORATORIES (ST. JUDE MEDICAL, INC.)
      • FIGURE 63     SWOT: ASHAI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
      • FIGURE 64     SWOT: AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION)
      • FIGURE 65     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 66     SWOT: BIOTRONIK SE & CO.KG
      • FIGURE 67     SWOT: LIVANOVA, PLC (SORIN GROUP)
      • FIGURE 68     SWOT: MEDTRONIC PLC
      • FIGURE 69     SWOT: NIHON KHODEN CORPORATION (DEFIBTECH)
      • FIGURE 70     SWOT: PHILIPS HEALTHCARE
      • FIGURE 71     SWOT: PHYSIO CONTROL INC (STRYKER CORPORATION)

      LIST OF COMPANIES MENTIONED IN REPORT

      • 1     3B SCIENTIFIC GMBH
      • 2     A.M.I. ITALIA S.R. L
      • 3     ABBOTT LABORATORIES
      • 4     ALLIED MEDICAL LIMITED
      • 5     ASAHI KASEI CORPORATION
      • 6     BEXEN CARDIO
      • 7     BIOTRONIK SE & CO. KG
      • 8     BOSTON SCIENTIFIC CORPORATION
      • 9     BPL MEDICAL TECHNOLOGIES
      • 10     CORPULS
      • 11     CU MEDICAL SYSTEMS INC
      • 12     CURA HEALTHCARE PVT LTD
      • 13     DIXION VERTRIEB MEDIZINISCHER GERÄTE GMBH
      • 14     ELECTROMEDICALS
      • 15     EMTEL SLIWA SP.K.
      • 16     FUKUDA DENSHI
      • 17     GAUMARD SCIENTIFIC
      • 18     HD1PY
      • 19     INNOMED MEDICAL DEVELOPING AND MANUFACTURING
      • 20     INSTRAMED
      • 21     INTEGER HOLDINGS CORPORATION
      • 22     LIFE PLUS MEDICAL INC
      • 23     LIFEBOT
      • 24     LIVANOVA PLC
      • 25     M&B ELECTRONIC INSTRUMENTS
      • 26     MEDIANA
      • 27     MEDICAL ECONET GMBH
      • 28     MEDITECH
      • 29     MEDTRONIC PLC
      • 30     METRAX GMBH
      • 31     METSIS MEDIKAL
      • 32     MINDRAY
      • 33     MINNESOTA WIRE 
      • 34     MS WESTFALIA GMBH
      • 35     NANOOMTECH
      • 36     NARANG MEDICAL LIMITED
      • 37     NASAN MEDICAL ELECTRONICS PVT LTD
      • 38     NIHON KOHDEN CORPORATION
      • 39     ORIENTMED INTERNATIONAL FZE 
      • 40     PHILIPS HEALTHCARE
      • 41     PROMED CO LTD
      • 42     RAPID DIAGNOSTICS PVT LTD
      • 43     RITIM GRUP AS
      • 44     ROTAID
      • 45     SCHILLER
      • 46     SHENZHEN XFT ELECTRONICS
      • 47     SIMULAIDS
      • 48     STRYKER CORPORATION
      • 49     TECHNO-GAZ
      • 50     US DEFIB MEDICAL TECHNOLOGIES
      • 51     WEINMANN EMERGENCY MEDICAL TECHNOLOGY
      • 52     XINCHENG SCIENTIFIC INDUSTRIES CO., LTD.
      • 53     YUAN TECHNOLOGY LIMITED